Loading insider details...
Beta
Latest Form 4 (Jul 9, 2026): Grant/Award of 37,500 CLRB shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 9, 2026 | Cellectar Biosciences, Inc. (CLRB) | Grant/Award | 37,500 | n/a |
| Mar 19, 2026 | MAXCYTE, INC. (MXCT) | Sale | 10,142 | $8.3K |
| Aug 13, 2025 | MAXCYTE, INC. (MXCT) | Purchase | 50,000 | $64.5K |
| Mar 20, 2025 | MAXCYTE, INC. (MXCT) | Sale | 6,939 | $22.1K |
| Mar 19, 2025 | MAXCYTE, INC. (MXCT) | Grant/Award | 37,500 | n/a |
| Feb 18, 2025 | Cellectar Biosciences, Inc. (CLRB) | Grant/Award | 90,000 | n/a |
| Jun 18, 2024 | Cellectar Biosciences, Inc. (CLRB) | Grant/Award | 90,000 | n/a |
| Mar 19, 2024 | MAXCYTE, INC. (MXCT) | Grant/Award | 81,250 | n/a |
| Jun 28, 2023 | Cellectar Biosciences, Inc. (CLRB) | Grant/Award | 37,500 | n/a |
| Mar 28, 2023 | MAXCYTE, INC. (MXCT) | Grant/Award | 350,000 | n/a |